Scinai Immunotherapeutics Ltd. - ADSs (BVXV)

Historical Holders from Q2 2015 to Q4 2022

Symbol
BVXV
CUSIP
09073Q105
Type / Class
Equity / ADSs
Shares outstanding
593K
All holders as of December 31, 2022
Q4 2022
Shares, excl. options
0
Holdings value
$0
Number of holders
0
Number of sells
-10
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Scinai Immunotherapeutics Ltd. - ADSs (BVXV)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SABBY MANAGEMENT, LLC 4.9% $26.7K 29.1K SABBY MANAGEMENT, LLC Dec 31, 2024

Institutional Holders of Scinai Immunotherapeutics Ltd. - ADSs (BVXV)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2022 Q4 0 $0 -$153K 0
2022 Q3 210K $153K -$106K $0.73 10
2022 Q2 333K $388K -$10.5K $1.17 12
2022 Q1 326K $538K -$99.4K $1.66 13
2021 Q4 336K $788K +$369K $2.35 12
2021 Q3 255K $560K -$195K $2.20 15
2021 Q2 311K $891K -$9.85K $2.86 15
2021 Q1 284K $1.08M +$263K $3.79 17
2020 Q4 221K $621K -$16.8M $2.81 9
2020 Q3 539K $21.1M +$2.4M $39.09 17
2020 Q2 506K $11.5M +$2.31M $22.75 14
2020 Q1 404K $3.12M -$3.45M $7.71 7
2019 Q4 477K $4.43M +$658K $9.24 10
2019 Q3 406K $2.41M $0 $5.72 7
2019 Q2 406K $2.34M -$63.1K $5.76 7
2019 Q1 417K $2.27M -$140K $5.43 9
2018 Q4 446K $2.13M +$106K $4.77 10
2018 Q3 449K $2.51M +$7.53K $5.60 11
2018 Q2 447K $2.98M -$159K $6.67 11
2018 Q1 475K $2.58M -$49.4K $5.42 13
2017 Q4 486K $2.61M +$130K $5.34 10
2017 Q3 96.2K $687K +$555K $7.14 7
2017 Q2 18.5K $162K -$254K $8.67 4
2017 Q1 62.7K $364K +$221K $5.81 4
2016 Q4 29K $101K -$13K $3.51 2
2016 Q3 32.5K $119K -$3K $3.67 3
2016 Q2 33.4K $118K +$2K $3.53 3
2016 Q1 32.8K $122K +$3K $3.73 3
2015 Q4 32K $126K -$60K $3.94 2
2015 Q3 48.2K $177K -$216K $3.71 5
2015 Q2 100K $495K +$495K $4.95 5